An increase in mean fluorescent intensity is due to the higher expression level of LRP in C6 glioma cells than BCEC, therefore which can easily be targeted by the SRL peptide (as a LRP ligand) present on the surface of nanoparticles. Here, SRL is linked to central nervous system cancer.